Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps …
Over the last 12 months, insiders at Sanara MedTech Inc. have bought $0 and sold $0 worth of Sanara MedTech Inc. stock.
On average, over the past 5 years, insiders at Sanara MedTech Inc. have bought $0 and sold $82,864 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,927,712 shares for transaction amount of $16M was made by Nixon Ronald T () on 2019‑10‑15.
2022-11-08 | Sale | Chief Executive Officer | 417 0.0053% | $33.00 | $13,761 | +19.97% | ||
2022-11-04 | Sale | Chief Executive Officer | 563 0.0071% | $33.00 | $18,579 | +20.33% | ||
2022-11-02 | Sale | Chief Executive Officer | 20 0.0003% | $33.02 | $660 | +32.08% | ||
2022-09-22 | Sale | Pres. - Strategic Partnerships | 1,000 0.0117% | $27.89 | $27,887 | +34.55% | ||
2022-07-05 | Sale | Chief Executive Officer | 750 0.0099% | $23.00 | $17,250 | +76.24% | ||
2022-06-28 | Sale | Chief Executive Officer | 294 0.0039% | $21.00 | $6,174 | +82.69% | ||
2022-06-24 | Sale | Chief Executive Officer | 457 0.0059% | $21.00 | $9,597 | +77.16% | ||
2022-06-17 | Sale | Pres. - Strategic Partnerships | 1,000 0.013% | $20.02 | $20,020 | +86.86% | ||
2021-10-26 | Sale | President - Surgical Div. | 1,000 0.0128% | $34.04 | $34,040 | -24.58% | ||
2021-10-20 | Sale | President - Wound Care Div. | 1,000 0.0133% | $34.19 | $34,191 | -21.82% | ||
2021-10-05 | Sale | President - Surgical Div. | 1,000 0.0128% | $33.10 | $33,104 | -22.17% | ||
2021-09-28 | Sale | President - Wound Care Div. | 1,000 0.0131% | $33.33 | $33,330 | -20.62% | ||
2019-10-15 | 1.93M 25.6795% | $8.30 | $16M | +50.00% | ||||
2019-10-15 | 361,446 4.8149% | $8.30 | $3M | +50.00% | ||||
2019-10-15 | 120,482 1.605% | $8.30 | $1M | +50.00% | ||||
2015-07-31 | 1,786 1.2257% | $69.99 | $125,000 | -30.00% | ||||
2015-07-31 | 1,786 – | $69.99 | $125,000 | -30.00% | ||||
2013-12-19 | director | 1,723 – | $0 | $0 | +11.11% | |||
2013-11-12 | CEO | 3,257 – | $0 | $0 | +42.86% | |||
2012-12-23 | Sale | director | 8,877 0.7705% | $3.00 | $26,631 |
COSSUTTA ARALDO A | director | 5259214 60.1261% | $35.05 | 2 | 5 | |
HAIRE SCOTT A | President & CEO | 4646403 53.1201% | $35.05 | 2 | 0 | |
EVANS STEVE W | 1348333 15.4148% | $35.05 | 1 | 0 | ||
Nixon Ronald T | 963856 11.0193% | $35.05 | 1 | 0 | +50% | |
STUCKERT JAMES W | 814830 9.3156% | $35.05 | 2 | 0 | +50% |
BlackRock | $90.46M | 104.88 | 9.05M | +4,318.25% | +$88.41M | <0.01 | |
State Street | $63.7M | 73.86 | 6.37M | +11,829.37% | +$63.17M | <0.01 | |
Geode Capital Management | $24.17M | 28.02 | 2.42M | +7.22% | +$1.63M | <0.01 | |
Boxer Capital, LLC | $15.45M | 17.91 | 1.54M | New | +$15.45M | 0.32 | |
Duquesne Family Office Llc | $9.84M | 11.41 | 984,000 | New | +$9.84M | 0.27 |